Ocular Therapeutix (OCUL) Misses Q3 EPS by 1c

Ocular Therapeutix (NASDAQ: OCUL) reported Q3 EPS of ($0.38), $0.01 worse than the analyst estimate of ($0.37). Revenue for the quarter came in at $14.54 million versus the consensus estimate of $14.63 million.

For earnings history and earnings-related data on Ocular Therapeutix (OCUL) click here.

You May Also Be Interested In

• Barrick Mining said to delay IPO of American gold business to 2027
• Popular stocks with increasing option volume: MU PLTR DELL INTC SPCX PCG AVGO SOFI MSTR NFLX IREN ORCL
• Amphenol (APH) call put ratio 1 call to 4.4 puts with a focus on 7100 contracts of October 135 puts